Ultivue Lands $5,150,000 Series A Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    763D Concord Avenue Cambridge, MA 02138 USA
  • Company Description
    Ultivue is an early stage life sciences tools company that seeks to provide the ultimate view into biology. Ultivue produces reagents that enable researchers to obtain microscopic images at an unprecedented resolution that vastly improve our understanding of biology and medicine.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    In addition to the Series A funding, Ultivue has received an exclusive license from Harvard University for the Wyss Institute’s DNA-PAINT and DNA-Exchange technologies and acquired the rights to other key enabling technology from California Institute of Technology.
  • M&A Terms
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
  • Venture Investor

Trending on Xconomy